MVSTW — Microvast Holdings, Inc.

Summary of Microvast's Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Annual Revenue: Achieved a record $427.5 million, a 12.6% increase from $379.8 million in 2024.
• Gross Margin: Reported at 28.6%, down from 31.5% in 2024, primarily due to a $32.5 million inventory impairment charge.
• Net Loss: GAAP net loss of $29.2 million, improved from a loss of $195.5 million in 2024.
• Non-GAAP Adjusted Profit: Achieved $13 million, compared to a loss of $84.6 million in 2024.
• Adjusted EBITDA: Recorded at $44.7 million, a significant turnaround from a negative $44.8 million in the previous year.
• Operating Cash Flow: Positive cash flow of $75.9 million, up from $2.8 million in 2024.
• Cash Position: Ended the year with $169.2 million in cash and equivalents.

2. Strategic Updates and Business Highlights

• Product Launches: Introduced a new 55 amp-hour cell and a next-generation LTO cell aimed at various high-demand applications.
• Huzhou Phase 3.2 Expansion: Progressing well with trial production underway, expected to add 2 GWh of annual production capacity.
• Regional Performance: U.S. revenue surged 173% year-over-year, while EMEA revenue grew 13%. APAC revenue slightly declined by 1%.
• Operational Efficiency: Significant reductions in operating expenses, particularly in general and administrative costs, which decreased by 29%.

3. Forward Guidance and Outlook

• 2026 Expectations: Anticipate continued revenue growth while navigating evolving tariff structures and geopolitical dynamics.
• Strategic Focus: Emphasis on high-margin deliveries, innovation, and expanding market share in high-value segments.
• Production Goals: Aiming for serial production in 2026 from the Huzhou expansion and maintaining operational efficiencies.

4. Bad News, Challenges, or Points of Concern

• Regulatory Challenges: Navigating a complex regulatory environment in South Korea impacted revenue and operational planning.
• Inventory Impairment: A significant inventory impairment charge negatively affected gross margins.
• Customer Platform Delays: Delays in customer platform ramp-ups in EMEA contributed to revenue performance falling slightly below guidance.

5. Notable Q&A Insights

• Market Dynamics: Management highlighted the importance of adapting to changing market conditions and tariffs, indicating a cautious yet optimistic approach.
• Investment in Domestic Capabilities: Discussion around the investment in the Clarksville facility to enhance domestic production capabilities and meet anticipated demand.
• Long-term Strategy: Emphasized a disciplined approach to navigating near-term challenges while focusing on building long-term shareholder value.

Overall, Microvast demonstrated resilience in 2025, achieving record revenues and significant operational improvements, despite facing regulatory and market challenges. The company is strategically positioned for growth in 2026 with a focus on innovation and efficiency.